Compare Stocks: IRMD, ITGR, LIVN, and PLSE

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRMD iRadimed	$88.27 -1.2%	$86.09	$73.02 ▼ $107.90	$1.14B	0.91	132,217 shs	78,800 shs
ITGR Integer	$126.70 0.0%	$125.97	$62.00 ▼ $126.79	$4.31B	0.58	878,590 shs	724,437 shs
LIVN LivaNova	$77.58 -1.2%	$78.54	$48.82 ▼ $85.76	$4.32B	0.87	678,632 shs	773,981 shs
PLSE Pulse Biosciences	$44.43 -2.5%	$49.82	$12.56 ▼ $58.90	$3.23B	1.57	483,644 shs	327,406 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRMD iRadimed	-0.51%	+4.06%	+8.45%	-7.89%	+22.17%
ITGR Integer	+0.08%	+0.07%	+0.42%	+32.62%	+22.18%
LIVN LivaNova	+3.18%	+3.41%	-1.22%	-2.73%	+46.67%
PLSE Pulse Biosciences	-1.58%	-8.78%	-17.41%	+58.96%	+163.68%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRMD iRadimed	$88.27 -1.2%	$86.09	$73.02 ▼ $107.90	$1.14B	0.91	132,217 shs	78,800 shs
ITGR Integer	$126.70 0.0%	$125.97	$62.00 ▼ $126.79	$4.31B	0.58	878,590 shs	724,437 shs
LIVN LivaNova	$77.58 -1.2%	$78.54	$48.82 ▼ $85.76	$4.32B	0.87	678,632 shs	773,981 shs
PLSE Pulse Biosciences	$44.43 -2.5%	$49.82	$12.56 ▼ $58.90	$3.23B	1.57	483,644 shs	327,406 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRMD iRadimed	-0.51%	+4.06%	+8.45%	-7.89%	+22.17%
ITGR Integer	+0.08%	+0.07%	+0.42%	+32.62%	+22.18%
LIVN LivaNova	+3.18%	+3.41%	-1.22%	-2.73%	+46.67%
PLSE Pulse Biosciences	-1.58%	-8.78%	-17.41%	+58.96%	+163.68%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRMD iRadimed	2.67	Moderate Buy	$120.00	35.95% Upside
ITGR Integer	2.07	Hold	$109.86	-13.29% Downside
LIVN LivaNova	2.73	Moderate Buy	$87.75	13.11% Upside
PLSE Pulse Biosciences	2.86	Moderate Buy	$60.20	35.49% Upside

Current Analyst Ratings Breakdown

Latest IRMD, ITGR, LIVN, and PLSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	PLSE Pulse Biosciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/13/2026	PLSE Pulse Biosciences	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$55.00
10/13/2026	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Outperform	$35.00 ➝ $60.00
10/7/2026	LIVN LivaNova	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong-Buy
10/6/2026	LIVN LivaNova	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Equal Weight ➝ Overweight	$105.00
10/6/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$43.00 ➝ $58.00
10/2/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (B-) ➝ Hold (C+)
9/23/2026	PLSE Pulse Biosciences	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$70.00
9/23/2026	PLSE Pulse Biosciences	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$70.00
9/22/2026	IRMD iRadimed	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Hold
9/14/2026	ITGR Integer	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Hold (C)

(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRMD iRadimed	$83.81M	13.47	$1.84 per share	48.08	$7.44 per share	11.86
ITGR Integer	$1.85B	2.32	$10.36 per share	12.23	$49.85 per share	2.54
LIVN LivaNova	$1.39B	3.08	$4.78 per share	16.23	$21.98 per share	3.53
PLSE Pulse Biosciences	$350K	8,987.55	N/A	N/A	$1.19 per share	37.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRMD iRadimed	$22.48M	$1.79	49.93	N/A	N/A	26.70%	23.45%	20.36%	11/2/2026 (Estimated)
ITGR Integer	$102.81M	$3.66	19.96	18.88	2.41	6.97%	12.79%	6.48%	10/22/2026 (Estimated)
LIVN LivaNova	-$242.47M	$3.38	21.87	18.65	N/A	12.82%	16.35%	7.76%	11/4/2026 (Estimated)
PLSE Pulse Biosciences	-$72.78M	-$1.18	N/A	N/A	N/A	-6,755.78%	-94.42%	-79.96%	11/4/2026 (Estimated)

Latest IRMD, ITGR, LIVN, and PLSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	LIVN LivaNova	$1.06	N/A	N/A	N/A	$381.10 million	N/A
11/4/2026	Q3 2026	PLSE Pulse Biosciences	-$0.35	N/A	N/A	N/A	$0.52 million	N/A
11/2/2026	Q3 2026	IRMD iRadimed	$0.55	N/A	N/A	N/A	$23.47 million	N/A
10/22/2026	Q3 2026	ITGR Integer	$1.68	N/A	N/A	N/A	$456.91 million	N/A
8/6/2026	Q2 2026	LIVN LivaNova	$1.09	$1.26	+$0.17	$1.93	$380.50 million	$390.59 million
8/6/2026	Q2 2026	PLSE Pulse Biosciences	-$0.2933	-$0.36	-$0.0667	-$0.36	$0.53 million	$0.43 million
8/3/2026	Q2 2026	ITGR Integer	$1.38	$1.60	+$0.22	$0.69	$451.07 million	$464.11 million
7/31/2026	Q2 2026	IRMD iRadimed	$0.44	$0.46	+$0.02	$0.41	$20.35 million	$20.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRMD iRadimed	$0.80	0.91%	N/A	44.69%	1 Years
ITGR Integer	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Latest IRMD, ITGR, LIVN, and PLSE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	IRMD iRadimed	quarterly	$0.20	0.92%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRMD iRadimed	N/A	9.46	8.13
ITGR Integer	0.75	3.73	2.41
LIVN LivaNova	0.22	1.45	1.21
PLSE Pulse Biosciences	N/A	9.63	9.61

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRMD iRadimed	92.34%
ITGR Integer	99.29%
LIVN LivaNova	97.64%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
IRMD iRadimed	34.60%
ITGR Integer	1.10%
LIVN LivaNova	0.35%
PLSE Pulse Biosciences	74.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRMD iRadimed	166	12.79 million	8.36 million	Optionable
ITGR Integer	11,000	34.00 million	33.62 million	Optionable
LIVN LivaNova	3,300	55.09 million	54.90 million	Optionable
PLSE Pulse Biosciences	116	70.80 million	18.41 million	Optionable

IRMD, ITGR, LIVN, and PLSE Headlines

Recent News About These Companies

Oppenheimer lifts target for Pulse Biosciences stock to USD 60.00

October 15 at 6:43 PM | ad-hoc-news.deA

Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center

October 14 at 9:14 AM | marketscreener.comM

Pulse Biosciences, Inc. Announces Commercial And Clinical Partnership With The Clayman Thyroid Center At The Hospital For Endocrine Surgery

October 14 at 9:14 AM | marketscreener.comM

Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule Treatment

October 14 at 9:14 AM | rttnews.com

Pulse Biosciences' 2027 Trial Readout Crucial to Evaluate New Pulsed Field Ablation Modality, Oppenheimer Says

October 13 at 6:46 PM | finance.yahoo.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 9, 2026

October 12, 2026 | biospace.comB

Head-To-Head Contrast: Pulse Biosciences (NASDAQ:PLSE) and NexGel (NASDAQ:NXGL)

October 11, 2026 | americanbankingnews.com

Why Pulse Biosciences (PLSE) Is Up 12.3% After Full NANOPULSE-AF Enrollment And nPulse Spotlight

October 10, 2026 | finance.yahoo.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 9, 2026 | businesswire.com

Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026

October 8, 2026 | finance.yahoo.com

Canaccord Genuity Sticks to Its Buy Rating for Pulse Biosciences (PLSE)

October 8, 2026 | theglobeandmail.com

Pulse Biosciences stock reaches 164 patient study target

October 8, 2026 | ad-hoc-news.deA

Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment

October 7, 2026 | tmcnet.com

Pulse Biosciences Reaches Enrollment Target in Nanopulse-AF Study

October 7, 2026 | marketscreener.comM

Pulse Biosciences, Inc. Achieves Enrollment Target In NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System For Atrial Fibrillation Treatment

October 7, 2026 | marketscreener.comM

Pulse Biosciences, Inc (NASDAQ:PLSE) Stock Has Average Target Price of $50.20

October 6, 2026 | americanbankingnews.com

Pulse Biosciences, Inc (NASDAQ:PLSE) Stock Has Average Price Target of $50.20

October 6, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down - Time to Sell?

October 5, 2026 | marketbeat.com

Pulse Biosciences stock faces Oppenheimer meeting after 3.87 percent fall

October 4, 2026 | ad-hoc-news.deA

Pulse Biosciences (PLSE) Stock Fair Value Rises After Analysts Back NsPFA Data

October 3, 2026 | finance.yahoo.com

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.1% - Here's Why

September 29, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, ITGR, LIVN, and PLSE Company Descriptions

iRadimed NASDAQ:IRMD

$88.27 -1.10 (-1.23%)

Closing price 04:00 PM Eastern

Extended Trading

$88.31 +0.04 (+0.05%)

As of 07:59 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Integer NYSE:ITGR

$126.70 -0.02 (-0.02%)

Closing price 03:59 PM Eastern

Extended Trading

$126.72 +0.02 (+0.01%)

As of 07:30 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova NASDAQ:LIVN

$77.58 -0.92 (-1.17%)

Closing price 04:00 PM Eastern

Extended Trading

$77.58 0.00 (0.00%)

As of 07:30 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Pulse Biosciences NASDAQ:PLSE

$44.43 -1.16 (-2.54%)

Closing price 04:00 PM Eastern

Extended Trading

$44.42 -0.02 (-0.03%)

As of 07:30 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IRMD, ITGR, LIVN, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IRMD, ITGR, LIVN, and PLSE Earnings

Compare Dividends

Latest IRMD, ITGR, LIVN, and PLSE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IRMD, ITGR, LIVN, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, ITGR, LIVN, and PLSE Company Descriptions

iRadimed NASDAQ:IRMD

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IRMD, ITGR, LIVN, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IRMD, ITGR, LIVN, and PLSE Earnings

Compare Dividends

Latest IRMD, ITGR, LIVN, and PLSE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IRMD, ITGR, LIVN, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, ITGR, LIVN, and PLSE Company Descriptions

iRadimed NASDAQ:IRMD

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools